Skip to content

Clinical observation of rimazolam for the prevention of postoperative delirium in elderly patients undergoing lower limb orthopaedic surgery

Clinical observation of rimazolam for the prevention of postoperative delirium in elderly patients undergoing lower limb orthopaedic surgery

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072592
Enrollment
Unknown
Registered
2023-06-19
Start date
2023-07-01
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative delirium

Interventions

Rimazolam sedation group (Group R):In group R, rimazolam 0.1mg/kg was given after plane fixation, followed by 5µg/kg/min continuous pumping until the BIS dropped to 75, then the infusion rate was grad

Sponsors

Dalian Municiple Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 95 Years

Inclusion criteria

Inclusion criteria: All sexes, age > 60 years, ASA Class I- III; patients undergoing elective lower limb orthopaedic surgery; patients who have signed the informed consent and subject declaration

Exclusion criteria

Exclusion criteria: Patient or family refusal to participate in the experiment; contraindications to combined lumbar and rigid anaesthesia (i.e. coagulation disorders, puncture site infection and refusal of combined lumbar and rigid anaesthesia); history of traumatic brain injury and brain surgery, preoperative history of schizophrenia, epilepsy, Parkinson's, myasthenia gravis; combined severe anaemia, history of psychotropic drug or alcohol abuse; combined severe cardiac insufficiency (left ventricular ejection fraction EF 1000ml, allergic to anaesthetic drugs, poor perioperative blood transfusion and anaesthesia; patients or family members with poor compliance; patients who have changed their treatment plan.

Design outcomes

Primary

MeasureTime frame
Postoperative delirium;Perioperative blood pressure;Perioperative heart rate;SPO2;Consumption of atropine;

Secondary

MeasureTime frame
VAS score;MMSE score;Consumption of norepinephrine;

Countries

China

Contacts

Public ContactCongjie Bi

Dalian Municiple Center Hospital

bcj0411@126.com+86 135 0425 1513

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026